期刊文献+

腹腔镜肝癌根治术对原发性肝癌的近期疗效及肝功能指标变化分析 被引量:9

下载PDF
导出
摘要 目的探讨腹腔镜肝癌根治术对原发性肝癌患者的近期疗效及肝功能指标变化。方法选取2016年6月至2017年12月江苏省徐州市肿瘤医院收治的68例原发性肝癌患者,采用随机数字表法分为对照组与观察组各34例。对照组患者采用传统开腹肝切除术,观察组患者采取腹腔镜肝切除术,分析比较两组患者的近期临床效果及肝功能指标变化。结果两组患者的术中出血量、肝门阻断时间及并发症发生率差异无显著性(P>0.05);观察组患者的手术时间长于对照组,视觉模拟评分、住院时间均显著低于对照组,差异有显著性(P<0.05)。两组患者术前肝功能指标差异无显著性(P>0.05);术后1周观察组患者总胆红素、谷丙转氨酶、谷草转氨酶及白蛋白均优于对照组,差异有显著性(P<0.05);观察组术后1周凝血酶原时间指标与术前差异无显著性(P>0.05)。观察组随访1年、2年的复发率显著低于对照组,观察组随访1年、2年的生存率显著高于对照组,差异有显著性(P<0.05)。结论腹腔镜肝癌根治术在不影响治疗效果的前提下可以减轻原发性肝癌患者的疼痛程度,缩短住院时间,改善肝功能水平,但手术时间较长。
出处 《中国临床医生杂志》 2020年第8期952-954,共3页 Chinese Journal For Clinicians
基金 江苏省徐州市引进临床医学专家团队项目(2018TD011)。
  • 相关文献

参考文献15

二级参考文献80

  • 1罗鹏飞,陈晓明,陆骊工,胡宝山,李勇.肝癌合并肝动脉门静脉瘘导致顽固性上消化道出血的诊断和治疗[J].中华放射学杂志,2007,41(4):401-404. 被引量:8
  • 2蔡秀军,戴益.腹腔镜肝脏切除术[J].腹部外科,2007,20(5):264-266. 被引量:9
  • 3Lin‐Feng Xu,Hong‐Liang Sun,Yao‐Ting Chen,Jia‐Yan Ni,Dong Chen,Jiang‐Hong Luo,Jing‐Xing Zhou,Ren‐Mei Hu,Qi‐Yun Tan.Large primary hepatocellular carcinoma: Transarterial chemoembolization monotherapy versus combined transarterial chemoembolization‐percutaneous microwave coagulation therapy[J].J Gastroenterol Hepatol.2013(3)
  • 4Alejandro Forner,Josep M Llovet,Jordi Bruix.Hepatocellular carcinoma[J].The Lancet.2012(9822)
  • 5Lu Wu,Ye-Fa Yang,Nai-Jian Ge,Shu-Qun Shen,Jun Liang,Yi Wang,Wei-Ping Zhou,Feng Shen,Meng-Chao Wu.Hepatic artery injection of 131I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study[J].European Journal of Nuclear Medicine and Molecular Imaging.2012(8)
  • 6JianJun Luo,ZhiPing Yan,QinXin Liu,XuDong Qu,JianHua Wang.Endovascular Placement of Iodine-125 Seed Strand and Stent Combined with Chemoembolization for Treatment of Hepatocellular Carcinoma with Tumor Thrombus in Main Portal Vein[J].Journal of Vascular and Interventional Radiology.2011(4)
  • 7Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
  • 8Xue-Bin Zhang,Jian-Hua Wang,Zhi-Ping Yan,Sheng Qian,Rong Liu.Hepatocellular Carcinoma Invading the Main Portal Vein: Treatment with Transcatheter Arterial Chemoembolization and Portal Vein Stenting[J].CardioVascular and Interventional Radiology.2009(1)
  • 9Zhao-Chong Zeng,Zhao-You Tang,Jia Fan,Lun-Xiu Qin,Shen-Long Ye,Jian Zhou,Hui-Chuan Sun,Bin-Liang Wang,Jian-Hua Wang.Consideration of role of radiotherapy for lymph node metastases in patients with HCC: Retrospective analysis for prognostic factors from 125 patients[J].International Journal of Radiation Oncology Biology Physics.2005(4)
  • 10Zhao-Chong Zeng,Jia Fan,Zhao-You Tang,Jian Zhou,Lun-Xiu Qin,Jian-Hua Wang,Hui-Chuan Sun,Bin-Liang Wang,Jian-Ying Zhang,Guo-Liang Jiang,Yu-Qi Wang.A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus[J].International Journal of Radiation Oncology Biology Physics.2005(2)

共引文献296

同被引文献134

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部